TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA® to Be Utilized in the Public Health Sector
Retrieved on:
월요일, 8월 23, 2021
Family, Health, Consumer, Women, Baby, Maternity, General Health, Pharmaceutical, Center, Centers for Medicare & Medicaid Services, Atrial fibrillation, Blood, J-CODE, Cancer, Forehead, Population, Skin, Population Council, Mouth, CMS, Weakness, Diabetes, HCPCS Level 2, Toxic shock syndrome, TSS, Medicare, Liver, Death, Chin, Heart, Thrombus, Vaginal bleeding, Hypoesthesia, Infection, Healthcare Common Procedure Coding System, NASDAQ, Risk, Patient, Headache, Depression, Public health, Angioedema, Liver disease, FDA, HCPCS, Smoke, Stroke, Progesterone, Breast cancer, Woman, Cholesterol, Triglyceride, Center for Medicare and Medicaid Innovation, Smoking, Medicine, Health insurance, Birth control, Medical imaging, Pharmaceutical industry, ANNOVERA, TherapeuticsMD, ANNOVERA, THERAPEUTICSMD
This new J Code will allow dispensing Public Health facilities the opportunity to gain reimbursement for ANNOVERA, including the approximately 4,900 Title X Family Planning clinics.
Key Points:
- This new J Code will allow dispensing Public Health facilities the opportunity to gain reimbursement for ANNOVERA, including the approximately 4,900 Title X Family Planning clinics.
- Public Health claims submission and payment are standardized with a J Code, facilitating and streamlining billing and reimbursement.
- Public Health insured patients represent a growing segment of the ANNOVERA user base.
- Having a permanent J Code will simplify Public Health billing and payment, further enhancing patient access to ANNOVERA in a growing segment of our user base.